about
Antimetastatic Therapies of the Polysulfide Diallyl Trisulfide against Triple-Negative Breast Cancer (TNBC) via Suppressing MMP2/9 by Blocking NF-κB and ERK/MAPK Signaling PathwaysDecreased HCRP1 expression is associated with poor prognosis in breast cancer patientsRB1 status in triple negative breast cancer cells dictates response to radiation treatment and selective therapeutic drugs.Contrasting breast cancer molecular subtypes across serial tumor progression stages: biological and prognostic implicationsGenetic polymorphisms and response to 5-fluorouracil, doxorubicin and cyclophosphamide chemotherapy in breast cancer patients.Knockdown of eIF4E suppresses cell growth and migration, enhances chemosensitivity and correlates with increase in Bax/Bcl-2 ratio in triple-negative breast cancer cells.Breast cancer survival in African-American women by hormone receptor subtypes.Demographic and clinico-pathological characteristics in patients with triple-negative and non-triple-negative breast cancer.Biological subtypes and survival outcomes in breast cancer patients with brain metastases (study of the Anatolian Society of Medical Oncology).Aspirin intake may prevent metastasis in patients with triple-negative breast cancer.
P2860
Q28546871-2461AD52-5A5A-4FAA-9EBB-311F414DB5B9Q34732984-F9E06AEF-505D-40E2-9232-E3E7952CB7F9Q35050328-E4006441-8F88-4C08-B64B-43AF5C1508F5Q36545146-B504154F-2E3F-4B51-8CA9-92F7AAE0F987Q37687072-A758795D-265F-47C8-A85C-5ADBCF81B30DQ39676973-9AFC434C-BDB1-494B-A072-01F26E66DCF3Q40650720-318A0D92-4CB9-4278-9AB2-A4F642B08F15Q44125298-EAD3E9EB-F3F3-4C02-A032-064C2020EB8CQ44625585-F2BDB730-1D55-418F-BAC9-A6C2EB0EC014Q54659492-2F573937-D80B-4E73-9DEF-D810B5C785EC
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pharmacotherapy of triple-negative breast cancer.
@en
Pharmacotherapy of triple-negative breast cancer.
@nl
type
label
Pharmacotherapy of triple-negative breast cancer.
@en
Pharmacotherapy of triple-negative breast cancer.
@nl
prefLabel
Pharmacotherapy of triple-negative breast cancer.
@en
Pharmacotherapy of triple-negative breast cancer.
@nl
P2093
P2860
P1476
Pharmacotherapy of triple-negative breast cancer.
@en
P2093
Cagatay Arslan
Kadri Altundag
Omer Dizdar
P2860
P304
P356
10.1517/14656560903117309
P407
P577
2009-09-01T00:00:00Z